Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
Peter N Freswick1, Elizabeth K Reid2, Maria R Mascarenhas2
1Helen DeVos Children's Hospital, Grand Rapids, MI 49503, USA.
Nutrients
|April 12, 2022
Summary
Cystic fibrosis (CF) often causes pancreatic insufficiency and nutritional issues. Early pancreatic enzyme replacement therapy (PERT) is crucial for managing CF complications, despite its complexities.
Area of Science:
- Gastroenterology
- Pulmonology
- Nutritional Science
Background:
- Cystic fibrosis is primarily viewed as a pulmonary condition.
- Pancreatic insufficiency is a common and serious complication in CF patients.
- Nutritional deficits and comorbidities significantly impact CF patient health.
Purpose of the Study:
- To highlight the importance of suspecting cystic fibrosis in patients with pancreatic insufficiency symptoms.
- To emphasize the urgent need for initiating pancreatic enzyme replacement therapy (PERT).
- To discuss the multifaceted considerations surrounding PERT for patients, dietitians, and clinicians.
Main Methods:
- Literature review on cystic fibrosis, pancreatic insufficiency, and PERT.
- Analysis of clinical guidelines and expert recommendations.
- Synthesis of information regarding PERT administration, efficacy, and challenges.
Main Results:
- High index of suspicion for CF is vital in patients presenting with pancreatic insufficiency.
- Prompt initiation of PERT is critical for mitigating nutritional complications.
- PERT involves diverse administration methods and potential for therapy failure and complications.
Conclusions:
- Cystic fibrosis management requires a multidisciplinary approach addressing both pulmonary and gastrointestinal aspects.
- Effective PERT is essential for improving nutritional status and overall outcomes in CF patients with pancreatic insufficiency.
- Ongoing clinical attention to PERT nuances, including administration and potential complications, is necessary.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.8K
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
8.2K
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
133
01:24Cystic Fibrosis: Management
230
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
230
01:23Cystic Fibrosis: Pathogenesis
382
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
382
01:26Pancreatic Juice and Secretion
1.6K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
1.6K
01:24Chronic Pancreatitis I: Introduction
184
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
184